165 related articles for article (PubMed ID: 12387669)
1. Clinical developments in reduced intensity haematopoietic stem cell transplantation.
Hogan WJ; Storb R
Expert Opin Biol Ther; 2002 Oct; 2(7):703-14. PubMed ID: 12387669
[TBL] [Abstract][Full Text] [Related]
2. Trends in hematopoietic stem cell transplant activity in Lebanon.
Bazarbachi A; Zahreddine A; Massoud R; El Cheikh J; Hanna C; Nasr F; Abboud M; Ibrahim A
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098
[TBL] [Abstract][Full Text] [Related]
3. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood.
Bakker B; Oostdijk W; Bresters D; Walenkamp MJ; Vossen JM; Wit JM
Bone Marrow Transplant; 2004 May; 33(10):1049-56. PubMed ID: 15048143
[TBL] [Abstract][Full Text] [Related]
4. Advances in pediatric hematopoietic stem cell transplantation.
Barfield RC; Kasow KA; Hale GA
Cancer Biol Ther; 2008 Oct; 7(10):1533-9. PubMed ID: 18927494
[TBL] [Abstract][Full Text] [Related]
5. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Georges GE; Storb R
Int J Hematol; 2003 Jan; 77(1):3-14. PubMed ID: 12568294
[TBL] [Abstract][Full Text] [Related]
6. Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives.
Grobbelaar S; Mercier AE; Verburgh E; Brittain D; Pepper MS
S Afr Med J; 2019 Sep; 109(8b):46-52. PubMed ID: 31662149
[TBL] [Abstract][Full Text] [Related]
7. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.
Atilla E; Ataca Atilla P; Demirer T
Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017
[TBL] [Abstract][Full Text] [Related]
8. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease.
Hogan WJ; Storb R
Immunol Res; 2003; 28(1):1-11. PubMed ID: 12947220
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?
Hough R; Cooper N; Veys P
Br J Haematol; 2009 Dec; 147(5):593-613. PubMed ID: 19709086
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic stem cell gene therapy in inborn errors of metabolism.
Chiesa R; Bernardo ME
Br J Haematol; 2022 Jul; 198(2):227-243. PubMed ID: 35535965
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation in inborn errors of metabolism.
Chiesa R; Wynn RF; Veys P
Curr Opin Hematol; 2016 Nov; 23(6):530-535. PubMed ID: 27662232
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in congenital disorders: A single-center experience.
Faraci M; Giardino S; Bagnasco F; Morreale G; Terranova MP; Di Martino D; Lanino E
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28649784
[TBL] [Abstract][Full Text] [Related]
15. Emerging concepts in haematopoietic cell transplantation.
Li HW; Sykes M
Nat Rev Immunol; 2012 May; 12(6):403-16. PubMed ID: 22627859
[TBL] [Abstract][Full Text] [Related]
16. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
Zhang Z; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
Yuan X; Sun ZM; Liu HL; Geng LQ; Wang ZY; Tong J; Yao W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):614-7. PubMed ID: 18549640
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic stem cell transplantation for autoimmune disorders.
Saccardi R; Di Gioia M; Bosi A
Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930
[TBL] [Abstract][Full Text] [Related]
19. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.
Sureda A; Bader P; Cesaro S; Dreger P; Duarte RF; Dufour C; Falkenburg JH; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Marsh JC; Nagler A; Peters C; Velardi A; Mohty M; Madrigal A
Bone Marrow Transplant; 2015 Aug; 50(8):1037-56. PubMed ID: 25798672
[TBL] [Abstract][Full Text] [Related]
20. Unrelated donor haematopoietic stem cell transplantation for adult patients with haematological malignancies.
Huang H; Lai XY
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):22-6. PubMed ID: 19494392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
